Alpha 2.0
Login Register
» Articles » PMID: 15735135

CASE 3. Pathologic Complete Remission of Metastatic Gastrointestinal Stromal Tumor After Imatinib Mesylate

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2005 Mar 1
PMID 15735135
Citations 6
Authors
Matias Chacon
Enrique Roca
Eduardo Huertas
Fernando Sanchez Loria
Enzo Domenechini
Affiliations
Soon will be listed here.
Citing Articles

Pathologic complete response to neoadjuvant imatinib of a gastric stromal tumor with concomitant mutations in : A case report and literature review.

Ben Rekaya M, Ksontini F, Bel Haj Kacem L, Sassi F, Harigua-Souiai E, Boujneh R Clin Case Rep. 2023; 11(6):e7463.

PMID: 37305871 PMC: 10248213. DOI: 10.1002/ccr3.7463.

Effective Downsizing of a Gastroesophageal GIST Using Neoadjuvant Imatinib Mesylate: a Case Report.

Asif S, Gupta N, Gupta G, Mehta A, Singh S J Gastrointest Cancer. 2016; 48(2):198-200.

PMID: 27006070 DOI: 10.1007/s12029-016-9816-6.

Get the GIST? An overview of gastrointestinal stromal tumours.

Watson G, Kelly D, Melland-Smith M, Gleeson J, McEntee G, Kelly C Ir J Med Sci. 2016; 185(2):319-26.

PMID: 26833487 DOI: 10.1007/s11845-016-1410-1.

Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST.

de Azevedo C, Paiva Jr T, Rossi B, Guimaraes G, Begnami M, Oliveira T Int J Clin Oncol. 2010; 16(3):279-83.

PMID: 20922448 DOI: 10.1007/s10147-010-0133-y.

Analysis of a case with disappearance of the primary gastrointestinal stromal tumor and progressive liver metastases under long-term treatment with tyrosine kinase inhibitors.

Cameron S, Savvoukidis T, Armbrust T, Haller F, Kitz J, Fuzesi L Med Oncol. 2009; 27(2):213-8.

PMID: 19294538 DOI: 10.1007/s12032-009-9193-0.